Black Tea Consumption and Risk of Skin Cancer: An 11-Year Prospective Study

被引:12
作者
Miura, Kyoko [1 ]
Hughes, Maria Celia B. [1 ]
Arovah, Novita Intan [1 ]
van der Pols, Jolieke C. [2 ]
Green, Adele C. [1 ,3 ]
机构
[1] QIMR Berghofer Med Res Inst, Canc & Populat Studies Grp, Brisbane, Qld, Australia
[2] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia
[3] Manchester Inst & Univ, Canc Res UK, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 2015年 / 67卷 / 07期
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
BASAL-CELL CARCINOMA; GREEN TEA; CAFFEINE; ASSOCIATION; POPULATION; PREVENTION; POISSON; PATHWAY;
D O I
10.1080/01635581.2015.1073759
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tea consumption has been shown to protect against skin carcinogenesis in laboratory-based studies; however, epidemiological evidence is limited and inconsistent. This prospective study examined the association between black tea consumption and the incidence of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Usual black tea consumption was estimated from food frequency questionnaires completed in 1992, 1994, and 1996 by 1,325 Australian adults. All histologically confirmed skin cancers diagnosed in participants from 1997 to 2007 were recorded. Relative risks (RRs) and 95% confidence intervals (CIs) were assessed using generalized linear models with Poisson and negative binomial distributions and adjusted for confounding factors including skin phenotype and sun exposure. Compared with never drinking black tea, drinking 4 cups/day was not associated with BCC (RR = 1.03, 95% CI: 0.70-1.53; P-trend = 0.74) or SCC (RR = 1.25, 95% CI: 0.71-2.19; P-trend = 0.29) in person-based analyses. Stratification by previous history of skin cancer as well as tumor-based analyses also showed no significant associations between black tea intake and incidence of BCC or SCC tumors. Our results do not support the hypothesis that high black tea consumption reduces risk of skin cancer, including in people with a previous history of skin cancer.
引用
收藏
页码:1049 / 1055
页数:7
相关论文
共 31 条
[1]   Association of Tea Consumption and Cutaneous Squamous Cell Carcinoma [J].
Asgari, Maryam M. ;
White, Emily ;
Warton, E. Margaret ;
Hararah, Mohammad K. ;
Friedman, Gary D. ;
Chren, Mary-Margaret .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2011, 63 (02) :314-318
[2]   The burden of skin diseases: 2004 - A joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology [J].
Bickers, David R. ;
Lim, Henry W. ;
Margolis, David ;
Weinstock, Martin A. ;
Goodman, Clifford ;
Faulkner, Eric ;
Gould, Ciara ;
Gemmen, Eric ;
Dall, Tim .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (03) :490-500
[3]  
Corona R, 2001, ARCH DERMATOL, V137, P1162
[4]   Tea, coffee, and caffeine and early-onset basal cell carcinoma in a case-control study [J].
Ferrucci, Leah M. ;
Cartmel, Brenda ;
Molinaro, Annette M. ;
Leffell, David J. ;
Bale, Allen E. ;
Mayne, Susan T. .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2014, 23 (04) :296-302
[5]   REGRESSION-ANALYSES OF COUNTS AND RATES - POISSON, OVERDISPERSED POISSON, AND NEGATIVE BINOMIAL MODELS [J].
GARDNER, W ;
MULVEY, EP ;
SHAW, EC .
PSYCHOLOGICAL BULLETIN, 1995, 118 (03) :392-404
[6]   Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial [J].
Green, A ;
Williams, G ;
Neale, R ;
Hart, V ;
Leslie, D ;
Parsons, P ;
Marks, GC ;
Gaffney, P ;
Battistutta, D ;
Frost, C ;
Lang, C ;
Russell, A .
LANCET, 1999, 354 (9180) :723-729
[7]   SKIN-CANCER IN A QUEENSLAND POPULATION [J].
GREEN, A ;
BEARDMORE, G ;
HART, V ;
LESLIE, D ;
MARKS, R ;
STAINES, D .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1988, 19 (06) :1045-1052
[8]   THE NAMBOUR SKIN-CANCER AND ACTINIC-EYE-DISEASE PREVENTION TRIAL - DESIGN AND BASE-LINE CHARACTERISTICS OF PARTICIPANTS [J].
GREEN, A ;
BATTISTUTTA, D ;
HART, V ;
LESLIE, D ;
MARKS, G ;
WILLIAMS, G ;
GAFFNEY, P ;
PARSONS, P ;
HIRST, L ;
FROST, C ;
ORRELL, E ;
DURHAM, K ;
LANG, C ;
AULD, J ;
BEARDMORE, G ;
COATES, J ;
CONGDON, S ;
MILLAR, P ;
MERCER, C ;
SINCLAIR, P ;
WAITE, S ;
WILSON, P ;
WEEDON, D ;
ASHTON, B ;
JEACOCKE, D ;
RUSSELL, A ;
NEALE, R ;
LUONG, T ;
READ, J .
CONTROLLED CLINICAL TRIALS, 1994, 15 (06) :512-522
[9]  
Green A, 1996, AM J EPIDEMIOL, V144, P1034, DOI 10.1093/oxfordjournals.aje.a008875
[10]  
Hakim I A, 2001, BMC Dermatol, V1, P3